Degraders have proven themselves at ER and the IMiD targets, and BTK is the only new target in reach of an approval through 2027. This is the interactive data behind our Protein Degraders Intelligence Report, Q3 2026, as of September 2026. Click any chart, card, or row to see what sits behind it.
